Thiopental as substitute therapy for critically ill patients with COVID-19 requiring mechanical ventilation and prolonged sedation
Med Intensiva (Engl Ed)
.
2022 Jan;46(1):58-61.
doi: 10.1016/j.medine.2020.07.004.
Authors
V Jean-Michel
1
,
T Caulier
1
,
P-Y Delannoy
1
,
A Meybeck
1
,
H Georges
2
Affiliations
1
Intensive Care Unit, Centre Hospitalier de Tourcoing, Tourcoing, France.
2
Intensive Care Unit, Centre Hospitalier de Tourcoing, Tourcoing, France. Electronic address: hgeorges@ch-tourcoing.fr.
PMID:
34991875
PMCID:
PMC8720977
DOI:
10.1016/j.medine.2020.07.004
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Critical Illness
Humans
Respiration, Artificial
SARS-CoV-2
Thiopental*
Substances
Thiopental